Posted on 7/9/18
Biogen And Eisai Tease An Alzheimer's Result
OK, we have kind of a complicated situation today. Biogen (NASDAQ:BIIB) and Eisai (EASLF) (EASLY) have press-released what appear to be positive results for an anti-amyloid . . .
Posted on 6/15/18
Finger-Pointing At Celgene
Just what is going on at Celgene (NASDAQ:CELG)? They've had some odd recent setbacks (such as the failure of Mongersen), and another such acquisition, Ozanimod, had . . .
Posted on 6/30/17
The Merck Malware Attack
As everyone will have seen, the last few days have brought news of yet another “ransomware” attack, this time from a piece of malware known most . . .
Posted on 6/1/17
Merck: An Approval Like No Other
Merck (NYSE:MRK) got an unusual approval at the FDA recently, for its Keytruda antibody in oncology. What’s new about it is that it is the first . . .

